Pitfalls in prion research

Medical Hypotheses

Volumn 54, Issue 5, 2000, Pages 698-700

  Peuschel, K E ^a  

^a NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

AMINO TERMINAL SEQUENCE; KNOCKOUT GENE; MEDICAL RESEARCH; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PURIFICATION; REVIEW; THEORY;

EID: 0034029018     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1999.0929     Document Type: Article

References (28)

1. Prusiner S. B., Groth D. F., Bolton C. D., Kent S. B., Hood L. E. Purification and structural studies of a major scrapie prion protein. Cell. 38:1984;127-134.
2. Hope J., Morton L. J., Farquhar C. F., Multhaup G., Beyreuther K., Kimberlin R. H. The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP). EMBO J. 5:1986;2591-2597.
3. Turk E., Teplow D. B., Hood L. E., Prusiner S. B. Purification and properties of the cellular and scrapie hamster prion proteins. Eur J Biochem. 176:1988;21-30.
4. Harris D. A., Huber M. T., van Dijken P., Shyng S. L., Chait B. T., Wang R. Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry US. 32:1993;1009-1016.
5. Safar J., Wang W., Padgett M. P. Molecular mass, biochemical composition and physicochemical behavior of the infectious form of the scrapie precursor protein monomer. Proc Natl Acad Sci USA. 87:1990;6373-6377.
6. Stahl N., Baldwin M. A., Teplow D. B. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry US. 32:1993;1991-2002.
7. Stahl N., Borchelt D. R., Prusiner S. B. Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C. Biochemistry US. 29:1990;54045-54012.
8. Hay B., Prusiner S. B., Lingappa V. R. Evidence for a secretory form of the cellular prion protein. Biochemistry US. 26:1987;8110-8115.
9. Hay B., Barry R. A., Lieberburg I., Prusiner S. B., Lingappa V. R. Biogenesis and transmembrane orientation of the cellular isoform of the scrapie prion protein. Mol Cell Biol. 7:1987;914-920.
10. Hegde R. S., Mastrianni J. A., Scott M. R. A transmembrane form of the prion protein in neurodegenerative disease. Science. 279:1998;827-834.
11. Bazan J. F., Fletterick R. J., McKinley M. P., Prusiner S. B. Predicted secondary structure and membrane topology of the scrapie prion protein. Protein Eng. 1:1987;125-135.
12. Baldwin M. A., Pan K. M., Nguyen J. Spectroscopic characterization of conformational differences between PrPC and PrPSc: an alpha-helix to beta-sheet transition. Philos T Roy Soc B. 343:1994;435-441.
13. Riek R., Hornemann S., Wider G., Glockshuber R., Wuthrich K. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 413:1997;262-268.
14. James T. L., Liu H., Ulyanov N. V. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci USA. 94:1997;10086-10091.
15. Gabizon R., McKinley M. P., Groth D. Immunoaffinity purification and neutralization of scrapie prions. Prog Clin Biol Res. 317:1989;583-600.
16. Pan K. M., Stahl N., Prusiner S. B. Purification and properties of the cellular prion protein from Syrian hamster brain. Protein Sci. 1:1992;1343-1352.
17. Sklaviadis T., Akowitz A., Manuelidis E. E., Manuelidis L. Nuclease treatment results in high specific purification of Creutzfeld-Jakob disease infectivity with a density characteristic of nucleic acid-protein complexes. Virology. 112:1990;215-228.
18. Bueler H., Fischer M., Lang Y. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 356:1992;577-582.
19. Manson J. C., Clarke A. R., Hooper M. L., Aitchison L., McConnell I., Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol. 8:1994;121-127.
20. Manson J. C., Hope J., Clarke A. R., Johnston A., Black C., MacLeod N. PrP gene dosage and long term potentiation. Neurodegeneration. 4:1995;113-115.
21. Sakaguchi S., Katamine S., Nishida N. Loss of cerebellar Purkinje cells in aged mice homzygous for a disrupted PrP gene. Nature. 380:1996;528-531.
22. Bellinger-Kawahara C., Cleaver J. E., Diener T. O., Prusiner S. B. Purified scrapie prions resist inactivation by UV irradiation. J Virol. 61:1987;159-166.
23. Alper T. The scrapie enigma: insights from radiation experiments. Radiat Res. 135:1993;283-292.
24. Prusiner, S. B. McKinley, M. P. Prions. New York, Academic Press, 1987.
25. Prusiner, S. B. Collinge, J. Powell, J. Anderton, B. Prion Diseases of Humans and Animals. Ellis Horwood, 1992.
26. Prusiner, S. B. Prions, Prions, Prions. Berlin, Springer, 1996.
27. Baker, H. F. Ridley, R. M. Prion Diseases. Humana Press, 1996.
28. Collinge, J. Palmer, M. S. Prion Diseases. Oxford, Oxford University Press, 1997.